UBS Group: Maintains 'Neutral' rating for Ali Health (00241), target price lowered to HKD 3.3.
UBS Group lowered its revenue forecast for Ali Health (00241) for the fiscal years 2025 to 2027 by 15% to 26%.
Alibaba releases Q1 results: revenue of 243.236 billion yuan, a year-on-year increase of 4%.
On the evening of August 15th, Sina Technology reported that Alibaba Group released its Q1 FY2025 (Q2 2024 of the calendar year) financial report, showing that the group's revenue for this quarter was RMB 243.236 billion, a YoY growth of 4%. Adjusted EBITA profit was RMB 45.035 billion, exceeding market expectations. The financial report shows that the operating efficiency of several businesses outside of e-commerce and cloud has improved and the level of commercialization has improved, with significant reduction in losses for businesses such as Ele.me and Lazada. "This quarter, we continue to invest in driving growth in core business, while other businesses achieve reduced losses by improving operational efficiency."
Alibaba's first financial report of the new fiscal year: The strategic investment has paid off, Taotian's market share is stable, and Alibaba Cloud is accelerating its growth.
On the evening of August 15th, Alibaba Group announced the financial results for the first quarter of the 2025 fiscal year. The focus on global strategy and continuous investment has yielded results, with the two core businesses of e-commerce and cloud computing continuing to make positive progress. Tmall Group's online GMV maintained stable growth, while Alibaba Cloud focused on 'public cloud + AI', with double-digit growth in public cloud revenue and triple-digit growth in AI-related product revenue. 'This quarter's performance demonstrates the effectiveness of our global strategy. We are focused on improving the user experience through good products, good prices and good services, driving stable market share for Tmall Group and returning our business to a growth trajectory. The positive momentum in cloud computing revenue growth is due to the public
Guotou Securities: The market share of listed pharmacies continues to increase, and the growth potential is expected to lead the industry.
In the context of a slowdown in the industry's growth rate, listed pharmacies are expected to achieve growth rates higher than the industry by virtue of their continuous rapid expansion of stores.
ALI HEALTH: FISCAL YEAR 2024 ANNUAL REPORT
Ali Health (00241) is suggested to adopt the 2024 stock incentive plan.
Ali Health (00241) announced that, in view of the adoption of the special general meeting of shareholders held on November 24, 2014...
